Established in 2004, this vertically integrated pharmaceutical manufacturer is committed to delivering high-quality, affordable medicines globally. As a CTD dossier owner and manufacturer, it holds GMP certifications from the US FDA, EU, and WHO, ensuring compliance with stringent international quality standards. The company's state-of-the-art R&D center is capable of handling oral solids, liquids, and parenteral formulations. Its products have received marketing authorizations from regulatory authorities such as the US FDA, Health Canada, CDSCO-India, and New Zealand. With over 20 ANDA/ANDs under approval, the manufacturer operates advanced production lines adhering to rigorous GMP guidelines. Its diverse portfolio includes therapeutics in areas like antivirals, neurology, women's health, cardiology, and imaging contrast agents.

Established in 2009, this manufacturer specializes in active pharmaceutical ingredients (APIs) and finished formulations, including tablets, capsules, and liquid orals. As a CTD dossier owner and manufacturer, it holds GMP certifications from international regulatory authorities, including the U.S. FDA and EU GMP, ensuring compliance with stringent quality standards. The manufacturer operates state-of-the-art production facilities in Vadodara and Vapi, India, adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across various regions, including Europe, East Asia, South America, and the Middle East. With a strong focus on research and development, the manufacturer is committed to delivering high-quality pharmaceutical solutions to meet global healthcare needs.